Success Stories: EB-1A Approved for a Postdoctoral Fellow in Maryland in the Field of Material Science
Client’s Testimonial:
Thanks a lot for your help!! [...] I would be happy to share my pleasant experiences with my colleagues and friends. [...] I will definitely like your page in Facebook and linkedIn.
On February 19th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the Field of Material Science (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Maryland
Approval Notice Date: February 19th, 2015
Processing Time: 1 month, 20 days (8 days after Requesting Premium Processing)
For this case we worked with a material scientist from India with a specialized focus on elucidating the behavior and characterization of bionanoparticles in the context of a variety of diseases, cancer therapy and medical devices. The client obtained his Ph.D. in the United States. His highly prolific career thus far had produced 18 peer-reviewed scientific articles, and he had been cited at least 236 times, primarily by independent researchers at prominent and leading institutions and organizations worldwide. This remarkable citation record clearly indicates the major significance of our client’s work. He had also reviewed at least 19 manuscripts for 11 or more distinctive, internationally-circulated journals. It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Material Science, and that his continued research would substantially and prospectively benefit the United States. An independent recommender affirmed the significance of our client’s research: “With [Client’s] research, we can stockpile devices that have a demonstrated ability to reduce adverse effects in humans. [Client’s] evaluation tool aligns with the Public Health Emergency Medical Countermeasures Enterprise strategy, which prioritizes resources with enduring capabilities…To meet the challenges and risks of our age in cost-effective, innovative ways, we must retain and support researchers such as [Client].” With the proof and documentation that we provided, his case was approved in 1 month and 20 days (8 days after requesting Premium Processing).